Wellington Management
http://www.wellington.comWellington Management is an independent investment management company. The firm invests in a broad range of asset classes including global equity, fixed income, currency and commodity markets, including multi-strategy, specialty and alternative investment approaches.
View Older Stories View More Recent Stories
-
Apogee Therapeutics Launches with $169 Million to Develop Potentially Best-in-Class Therapies for Immunological and Inflammatory Disorders
-
E-commerce tech startup Rokt valued at $2.4 billion in latest funding amid plans for IPO
-
Rokt Announces Secondary Transaction, Increasing Valuation to US$2.4 Billion
-
Scribe Therapeutics to Participate in Four Upcoming Conferences
-
Immatics Announces Third Quarter 2022 Financial Results and Business Update
-
Immatics Announces Third Quarter 2022 Financial Results and Business Update
-
AMP Robotics establishes new headquarters in Louisville
-
Form 13F-HR WELLINGTON MANAGEMENT For: Sep 30
-
MBX Biosciences Closes $115 Million Series B Financing to Advance Development of Endocrine Disease Programs
-
Form SC 13G/A UCB S.A. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A VISTEON CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A CommScope Holding Compan Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Perella Weinberg Partner Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Cinemark Holdings, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A VARONIS SYSTEMS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Olo Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics
-
Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics
-
FalconX 360 Recognized as the Most Innovative FinTech Solution by the 2022 Tech Ascension Awards
-
AMP Robotics Raises $91 Million in Series C Financing
-
Eventide Announces Hire of Jennifer Reiche as Chief Compliance Officer
-
Current migrates to Visa DPS Forward Platform; Innovative integration to enable suite of new financial products
-
Zero Hash partners with Current to provide access to no-fee crypto trading
-
Zero Hash partners with Current to provide access to no-fee crypto trading
-
Publicis Groupe : Third Quarter 2022 Revenue
-
Publicis Groupe : Third Quarter 2022 Revenue
-
Publicis Groupe: Third Quarter 2022 Revenue
-
Top 500 asset managers reach new $131 trillion record
-
FalconX 360 Launches As The First and Only Comprehensive Platform for Institutional Crypto Investment Management
-
Form SC 13G Nuvei Corp Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Vanguard Announces Changes for Vanguard International Explorer Fund
-
Form SC 13G/A Payoneer Global Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A COHERENT CORP. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A INTEGRA LIFESCIENCES Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SC 13G/A Patria Investments Ltd Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Immatics (IMTX) Announces $110 Million Underwritten Offering of Ordinary Shares
-
Immatics Announces $110 Million Underwritten Offering of Ordinary Shares
-
Immatics Announces $110 Million Underwritten Offering of Ordinary Shares
-
Major Shareholder Announcement
-
Major Shareholder Announcement
-
BetterUp Appoints Psychologist Adam Grant as Chairman of Newly Launched Center for Purpose and Performance
-
Revelation Partners Expands Team and Appoints New Partners Fred Lee and Liz Staley
-
Over 500 Preservation Leaders at Historic New England Summit in Worcester, MA, October 13-14
-
Cohen & Steers Announces Succession of Japan Country Head
-
JOHN HANCOCK HEDGED EQUITY & INCOME FUND REQUIRED NOTICE TO SHAREHOLDERS - SOURCES OF DISTRIBUTION UNDER SECTION 19(a)
-
Scribe Therapeutics to Participate in Upcoming Investor Conferences
-
Scribe Therapeutics Announces Research Collaboration with Sanofi to Accelerate Breakthrough CRISPR-based Cell Therapies for Cancer
-
As deadline looms, some Swedish Match investors oppose Philip Morris deal
-
RayzeBio Propels Forward with $418 Million Raised Since Inception to Advance Targeted Radiopharmaceuticals for Cancer
-
Soundcore's Deal Origination team hires another

